어플

Hyundai Pharmaceutical's hair loss treatment 20,000 bottles are recalled

Business / 김지선 / 07/03/2023 05:10 AM

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Hyundai Pharmaceutical is collecting the drug after it was reported that the hair loss treatment drug on sale is mixed with dementia treatment.

It is known that the products subject to recall are mixed with dementia treatments. This was revealed through a pharmacist's report. About 20,000 bottles of recalled products are said to have been produced.

The Ministry of Food and Drug Safety and Hyundai Pharmaceutical are announcing the recall of the product in question through the company's website. Separately, the Ministry of Food and Drug Safety is investigating how the incident occurred and whether consumers took it.

 

 

AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)

Related articles

[Exclusive] Samsung Electronics to Supply HBM3E 12-High Stacks to NVIDIA
DL E&C Executives Resign En Masse Following Fatal Construction Site Accident
POSCO Future M Terminates KRW 945 Billion ESS Cathode Material Supply Contract, Signs New LFP Partnership with CNGR
Hahn & Company Selects TKG Taekwang as Preferred Bidder for Sale of Semiconductor Parts Maker Solmix
Hyundai Motor Group Bolsters SDV and Autonomous Driving Capabilities with KRW 500.3 Billion Investment in 42dot
comments >

SNS